| Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization K Bajou, A Noël, RD Gerard, V Masson, N Brunner, C Holst-Hansen, ... Nature medicine 4 (8), 923-928, 1998 | 870 | 1998 |
| The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies K Bajou, V Masson, RD Gerard, PM Schmitt, V Albert, M Praus, LR Lund, ... The Journal of cell biology 152 (4), 777-784, 2001 | 418 | 2001 |
| The pro‐or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent L Devy, S Blacher, C Grignet-Debrus, K Bajou, V Masson, RD Gerard, ... The FASEB journal 16 (2), 147-154, 2002 | 348 | 2002 |
| Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation EN Baramova, K Bajou, A Remacle, C L'hoir, HW Krell, UH Weidle, ... FEBS letters 405 (2), 157-162, 1997 | 339 | 1997 |
| The antitumoral effect of endostatin and angiostatin is associated with a down‐regulation of vascular endothelial growth factor expression in tumor cells A Hajitou, C Grignet‐Debrus, L Devy, S Berndt, S Blacher, CF Deroanne, ... The FASEB journal 16 (13), 1-23, 2002 | 276 | 2002 |
| Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes V Masson, LR De La Ballina, C Munaut, B Wielockx, M Jost, C Maillard, ... The FASEB journal: official publication of the Federation of American …, 2005 | 240 | 2005 |
| Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth K Bajou, C Maillard, M Jost, RH Lijnen, A Gils, P Declerck, P Carmeliet, ... Oncogene 23 (41), 6986-6990, 2004 | 204 | 2004 |
| Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis K Bajou, H Peng, WE Laug, C Maillard, A Noel, JM Foidart, JA Martial, ... Cancer cell 14 (4), 324-334, 2008 | 177 | 2008 |
| Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis V Masson, L Devy, C Grignet-Debrus, S Bernt, K Bajou, S Blacher, ... Biological procedures online 4, 24-31, 2002 | 174 | 2002 |
| Role of plasminogen activator-plasmin system in tumor angiogenesis JM Rakic, C Maillard, M Jost, K Bajou, V Masson, L Devy, V Lambert, ... Cellular and Molecular Life Sciences CMLS 60, 463-473, 2003 | 173 | 2003 |
| Emerging roles for proteinases in cancer A Noël, C Gilles, K Bajou, L Devy, F Kebers, JM Lewalle, E Maquoi, ... Invasion and metastasis 17 (5), 1997 | 158 | 1997 |
| Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization V Lambert, C Munaut, F Frankenne, K Bajou, R Gerard, P Carmeliet, ... FASEB Journal 15 (6), 2001 | 127 | 2001 |
| PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin K Bajou, S Herkenne, VL Thijssen, S D'amico, NQN Nguyen, A Bouché, ... Nature medicine 20 (7), 741-747, 2014 | 111 | 2014 |
| Alteration of interendothelial adherens junctions following tumor cell–endothelial cell interactionin vitro JM Lewalle, K Bajou, J Desreux, M Mareel, E Dejana, A Noël, JM Foidart Experimental cell research 237 (2), 347-356, 1997 | 71 | 1997 |
| Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization JM Rakic, V Lambert, C Munaut, K Bajou, K Peyrollier, ... Investigative ophthalmology & visual science 44 (4), 1732-1739, 2003 | 66 | 2003 |
| Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner C Maillard, M Jost, MU Rømer, N Brunner, X Houard, A Lejeune, ... Neoplasia 7 (1), 57-66, 2005 | 58 | 2005 |
| The plasminogen–activator plasmin system in physiological and pathophysiological angiogenesis AA Ismail, BT Shaker, K Bajou International journal of molecular sciences 23 (1), 337, 2021 | 57 | 2021 |
| Endothelial cell intracellular Ca concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration JM Lewalle, D Cataldo, K Bajou, CA Lambert, JM Foidart Clinical & experimental metastasis 16, 21-29, 1998 | 56 | 1998 |
| The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis S Herkenne, C Paques, O Nivelles, M Lion, K Bajou, T Pollenus, ... Science signaling 8 (403), ra117-ra117, 2015 | 53 | 2015 |
| DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase M Amand, C Erpicum, K Bajou, F Cerignoli, S Blacher, M Martin, ... Molecular cancer 13, 1-18, 2014 | 53 | 2014 |
